- cafead Feb 15, 2024 at 07:23: PM
via Osivax has vaccinated the first participant with the investigational sarbecovirus vaccine OVX033 in Paris, commencing the start of the 48-participant trial.
article source
article source
-
Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page
Osivax kicks off broad spectrum coronavirus vaccine trial
- Thread starter cafead
- Start date
<
Similar threads